Mural Oncology
(MURA)
undefined
undefined%
At close: undefined
3.64
0.69%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 |
Net Income | -207.45M | -189.81M | -175.43M |
Depreciation & Amortization | 2.57M | 1.54M | 1.47M |
Stock-Based Compensation | 24.11M | 11.93M | 11.50M |
Other Working Capital | -13.48M | 7.75M | 5.79M |
Other Non-Cash Items | - | 15.01M | 14.45M |
Deferred Income Tax | - | -15.01M | -14.45M |
Change in Working Capital | -13.48M | 7.75M | 5.79M |
Operating Cash Flow | -194.25M | -168.59M | -156.67M |
Capital Expenditures | -3.45M | -5.51M | -4.38M |
Acquisitions | - | - | - |
Purchase of Investments | - | - | - |
Sales Maturities Of Investments | - | - | - |
Other Investing Acitivies | - | - | - |
Investing Cash Flow | -3.45M | -5.51M | -4.38M |
Debt Repayment | - | - | - |
Common Stock Repurchased | - | - | - |
Dividend Paid | - | - | - |
Other Financial Acitivies | 468.81M | 174.10M | 161.05M |
Financial Cash Flow | 468.81M | 174.10M | 161.05M |
Net Cash Flow | 271.11M | - | - |
Free Cash Flow | -197.70M | -174.10M | -161.05M |